Comparative Renal Tubular Toxicity of Chemotherapy Regimens Including Ifosfamide in Patients With Newly Diagnosed Sarcomas
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference24 articles.
1. Ifosfamide plus etoposide in newly diagnosed Ewing's sarcoma of bone.
2. No benefit of ifosfamide in Ewing's sarcoma: a nonrandomized study of the French Society of Pediatric Oncology.
3. A phase II trial of ifosfamide in previously untreated children and adolescents with unresectable rhabdomyosarcoma
Cited by 42 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Outcomes of Window Therapy with Carboplatin and Ifosfamide for Pediatric Osteosarcoma: A Case Series;Children;2023-04-17
2. Excellent Tolerability of Ifosfamide and Mesna Via Continuous Infusion in a Pediatric Patient Population;Journal of Pediatric Hematology/Oncology;2021-12-03
3. The Role of Oxidative Stress and Inflammation in Cardiometabolic Health of Children During Cancer Treatment and Potential Impact of Key Nutrients;Antioxidants & Redox Signaling;2021-08-01
4. Prevalence and Predictors of Frailty in Childhood Cancer Survivors and Siblings: A Report From the Childhood Cancer Survivor Study;Journal of Clinical Oncology;2020-01-20
5. Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer;Cochrane Database of Systematic Reviews;2019-03-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3